This English-language Master's programme, a joint initiative between the Medical University of Innsbruck and the University of Innsbruck, focuses on the scientific and regulatory aspects of drug development. It aims to train experts who possess a comprehensive understanding of the entire process involved in creating new medicinal products. The curriculum covers preclinical and clinical drug development, quality assurance, regulatory frameworks for market authorization in Europe, and data management, preparing graduates for roles in pharmaceutical companies, regulatory authorities, and research organizations.
The curriculum is designed to provide a thorough understanding of drug development processes and regulatory requirements. Key areas include preclinical development, quality control, clinical trials, good practices (manufacturing, clinical, laboratory), biostatistics, regulatory affairs, and pharmacoeconomics.
Graduates of this programme are well-prepared for a variety of roles in the pharmaceutical industry and regulatory sector.
While a completed bachelor's degree is not required for the initial application, it must be obtained by the end of the admission period for enrollment. Applicants must also meet general university entrance qualification requirements.
Tuition fees are subject to change. Non-EU/EEA students should verify the exact fees for the relevant academic year.
This is a Master of Science (MSc) degree, aligned with Level 7 of the European Qualifications Framework (EQF).
This Master's program lasts for 4 semesters (2 years) and is taught entirely in English.
EU/EEA citizens do not pay tuition fees. Non-EU/EEA citizens pay approximately €726.72 per semester (as of 2023/24).
You need a relevant Bachelor's degree (e.g., Pharmacy, Chemistry, Biology) or an equivalent degree. If there are significant subject differences, supplementary examinations may be required.
The application procedure is managed by the Medical University of Innsbruck, with final admission at the University of Innsbruck. You need to check admission requirements, prepare documents like your Bachelor's degree certificate and transcripts, register for the admission procedure, and complete the application at the University of Innsbruck.
Graduates are prepared for roles in pharmaceutical companies, regulatory authorities, clinical research organizations, and can pursue further doctoral studies in academia.